Home » Newsletters » BioWorld Science

BioWorld Science

July 29, 2020

View Archived Issues

AHR inhibition suppresses Zika infection

[124/131I]-MSK-PSMA1, a new radioiodinated theranostic agent for PSMA-positive prostate cancer

[89Zr]DFO-elotuzumab as novel imaging agent in patients with MM

EBV drives gastric cancer by rewiring host epigenomes

Suzhou Zelgen Biosciences identifies new MAP3K5 inhibitors

Dihydroorotate dehydrogenase inhibitors discovered at Janssen

Cascade (Shanghai) Pharmaceutical Technology patents AMPK activators

New PDE9 inhibitors synthesized at Nanjing TransThera Biosciences

Gruenenthal presents glucocorticoid receptor modulators

Series A financing to support ExeVir's development of VHH-72-Fc for COVID-19

Enrollment starts in phase IIa study of tegavivint in desmoid tumors

PIK3C2B blockade protects against ischemic stroke and preserves vascular integrity

FDA clears first IND application for RLS-0071

Reata announces investigator-sponsored trial of bardoxolone in patients with COVID-19

First patient dosed in investigator-initiated study of infigratinib in recurrent glioblastoma

European Commission grants approval for Xenleta as treatment of CAP

COVACTA trial of Actemra in severe COVID-19-associated pneumonia misses endpoints

Phase III REFALS trial of oral levosimendan in ALS does not meet endpoints

Mucolipin-1 is a therapeutic target in Alzheimer's disease

Krystal begins phase III study of beremagene geperpavec for dystrophic epidermolysis bullosa

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...